This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Akerstroem G, Hellmann P, Hessmann O et al (2005) Management of midgut carcinoids. J Surg Oncol 89:161–169
Auernhammer CJ, Göke B (2011) Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin. Gut 60:1009–1021
Auernhammer CJ, Assmann G, Bartenstein P, Becker K, Berberat P, Göke B, Gross M, Grosu AL, Heinemann V, Helmberger T, Herrmann K, Höfler H, Hoffmann J, Hoffmann R-T, Perren A, Pöpperl G, Pigorsch SU, Scheidhauer K, Spitzweg C, Waldner H, Weiß W, Vogelsang H (2008) Tumormanual Endokrine Tumoren. Zuckschwerdt Verlag, München
Auernhammer CJ, Jauch KW, Hoffmann JN (2009) Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system – therapeutic strategies. Zentralbl Chir 134(5):410–417
Capella C, Heitz P, Höfler H, Solcia E, Klöppel G (1995) Revised classification of neuroendocrine tumors of the lung, pancreas and gut. Virchows Arch 425:547–560
Hellmann P et al (2002) Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World Journal of Surgery 26:991–997
Hoffmann JN, Jauch KW (2009) Chirurgische Therapie neuroendokriner, nicht pankreatischer Tumoren des Gastrointestinaltrakts unter Berücksichtigung der Lebermetastasen. Verdauungskrankheiten 27:219–227
Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S (2010) The Pathologic Classification of Neuroendocrine Tumors. Pancreas 39(6):707–712
Kwekkeboom DJ, Krenning EP (1996) Somatostatin receptor Imaging. Semin Nucl MED 32:84–91
Oberg K, Kvols L, Caplin M, Delle Fave G, de Herder W, Rindi G, Ruszniewski P, Woltering EA, Wiedenmann B (2004) Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 15(6):966–973
Richards ML et al (2002) Pitfalls in the surgical management of insulinoma. Surgery 132:1040–1049
Rindi et al (2006) TNM staging for foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401
Rindi G, Klöppel G, Couvelard A, Komminoth P, Körner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B (2007) TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 451(4):757–762
Schott M, Klöppel G, Raffel A, Saleh A, Knoefel WT, Scherbaum WA (2011) Gastroenteropankreatische neuroendokrine Neoplasien. Dtsch Arztebl Int 108:305–312
Steinmüller et al (2008) Consensus guidelines fort the management of patients with liver metastases from digestive neuroendocrine tumors: Foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 87:47–62
Van Vilsteren et al (2006) Liver transplantation for gastropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transplant 12:448–456
Yao J et al (2001) Indications and results for liver resection and hepatic chemoembolisation for metastatic gastrointestinal neuroendocrine tumors. Surgery 130:677–682
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Göke, B., Hoffmann, J. (2015). Neuroendokrine Tumoren des Gastrointestinaltrakts. In: Erckenbrecht, J., Jonas, S. (eds) Viszeralmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-14301-4_39
Download citation
DOI: https://doi.org/10.1007/978-3-642-14301-4_39
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-14300-7
Online ISBN: 978-3-642-14301-4
eBook Packages: Medicine (German Language)